Benjamin F. McGraw Iii.

Chief Executive Officer, Vaneltix Pharma, Inc.

Companies

Evommune, Inc.Board member Nov 5, 2025 to now¹
Aerie PharmaceuticalsBoard member Oct 10, 2014 to Nov 21, 2022²
Aerie PharmaceuticalsChair Sep 22, 2021 to Mar 2, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aerie Pharmaceuticals AERI0 shares⁴Nov 21, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 21, 2022Returned to company 41,984 shares at $15.25 of Aerie Pharmaceuticals⁴
Jun 9, 2022Granted 6,245 shares of Aerie Pharmaceuticals⁵
Feb 28, 2022Shares withheld for tax 10,324 shares at $8.30 of Aerie Pharmaceuticals⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREvommune, Inc., Board member
2
SEC EDGARAerie Pharmaceuticals, Board member
3
SEC EDGARAerie Pharmaceuticals, Chair
4
SEC EDGARAerie Pharmaceuticals shares after the filing of Nov 21, 2022
5
SEC EDGARForm 4 filed Jun 13, 2022
6
SEC EDGARForm 4 filed Mar 2, 2022